Clinic News

Latest in Cardiology

Micro- and Nanoplastics Found in Patients With STEMI, CCS
Levels of microplastics and nanoplastics (MNPs) in coronary blood were higher in patients with a STEMI than those with chronic coronary syndromes (CCS) or in controls, according to a cross-sectional study published July 14 in the EHJ.
Better Safety Profile, TR Reduction With T-TEER Than TTVA, Similar Outcomes at 1 Year
In patients with severe secondary tricuspid regurgitation (TR), tricuspid valve transcatheter edge-to-edge repair (T-TEER), compared with transcatheter tricuspid valve annuloplasty (TTVA), showed a more favorable safety profile and a more effective and durable reduction in TR, while clinical outcomes at one year were similar with both strategies, according to research published July 22 in JACC: […]
CKM Syndrome Associated With Increased, Stage-Specific Cancer Risk
Cardiovascular-kidney-metabolic (CKM) syndrome is associated with incremental cancer risk and stage-specific immune-metabolic pathways, according to a study using data from the UK Biobank published July 16 in JACC: CardioOncology. These findings highlight potential prevention targets.
If You Build It, Will They Come? Digital Health in AF Management
Atrial fibrillation (AF) is the most common sustained arrhythmia in the United States, with a nation-wide prevalence projected to reach 12.1 million by 2030.1 AF is a major driver of adverse clinical outcomes, including stroke, dementia, myocardial infarction, sudden cardiac death, heart failure, chronic kidney disease, and all-cause death.
ACC CardiaCast: Beyond the Kidneys: UACR and Cardiovascular Risk
Dr. Ankeet Bhatt interviews Dr. Nihar Desai on key terminology for albuminuria and discuss CV conditions associated with UACR as a biomarker.
Updated ACC Expert Consensus Decision Pathway Addresses Management of HFpEF
The updated 2026 ACC Expert Consensus Decision Pathway (ECDP) for the Management of Heart Failure With Preserved Ejection Fraction (HFpEF) reflects a significant evolution in how HFpEF is understood and treated.
DAPT-MVD: Extended DAPT Cuts CV Events After PCI in Multivessel CAD
Extending DAPT for an additional year reduced major adverse cardiovascular events (MACE) without increasing bleeding risk compared with aspirin alone among patients with multivessel coronary artery disease (MVCAD) who had no ischemic or bleeding events one year after PCI with a drug-eluting stent, according to results of the DAPT-MVD trial published July 15 in NEJM.
ACC Announces 2027 Officers and New Trustees
The ACC Board of Trustees (BOT) has approved the College's next slate of officers and new trustees, who will begin their terms in April 2027 following ACC's Annual Scientific Session in Houston, TX.
Does Influenza Vaccination Reduce AFib Risk?
Influenza vaccination was associated with lower risks of incident atrial fibrillation (AFib) and multiple cardiovascular outcomes, according to an observational cohort study published July 11 in EHJ. The findings support vaccination as a potential AFib prevention strategy and underscore the need for randomized trials focused on AFib-related outcomes.
GBD 2023: High SBP, Diet and High LDL-C Top Drivers of US IHD Deaths
Nearly 90% of ischemic heart disease (IHD) deaths in 2023 in the U.S. were attributable to modifiable risk factors, led by high systolic blood pressure (SBP), dietary risks and high LDL-C, according to data from the Global Burden of Disease Study 2023 (GBD 2023), published July 15 in JAMA Cardiology.